Myelodysplastic syndromes in children: where are we today?

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Ochsner Journal

• Publication date

  2012-09-17

• Fields of study

  Medicine

• Identifiers
  PMID 23049458PMCID PMC3448243
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study

  2011cited by this paper
• Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study

  2010cited by this paper
• Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome.

  2010cited by this paper
• Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remissions.

  2010cited by this paper
• Mutation in TET2 in myeloid cancers.

  2009cited by this paper
• Treatment of children with refractory anemia: The Japanese Childhood MDS Study Group trial (MDS99)

  2009cited by this paper
• Advanced pediatric myelodysplastic syndromes: Can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?

  2009cited by this paper
• The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

  2009cited by this paper
• Bone marrow cell cycle markers in inherited bone marrow failure syndromes.

  2008cited by this paper
• Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study.

  2007cited by this paper
• Reduced intensity conditioning in unrelated donor transplantation for refractory cytopenia in childhood

  2007cited by this paper
• TUMORS OF HEMATOPOIETIC AND LYMPHOID TISSUES

  2007cited by this paper
• Comparison of two new classifications for pediatric myelodysplastic and myeloproliferative disorders

  2005cited by this paper
• A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases

  2003cited by this paper
• Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7.

  2003cited by this paper
• Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia in the UK: a population‐based study of incidence and survival

  2003cited by this paper
• E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues

  2002cited by this paper
• Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program.

  2002cited by this paper
• Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

  2002cited by this paper
• World Health Organization classification of tumors

  2000cited by this paper
• The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes

  1999cited by this paper
• The Wilms’ tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes

  1999cited by this paper
• Myelodysplastic syndrome in children: differentiation from acute myeloid leukemia with a low blast count

  1997cited by this paper
• Pathogenesis, biology, and management of myelodysplastic syndromes in children.

  1996influential reference
• Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia.

  1996cited by this paper
• Childhood myelodysplastic syndrome in Denmark: incidence and predisposing conditions.

  1995cited by this paper
• Myelodysplastic syndrome in a child with constitutional trisomy 8 mosaicism and normal phenotype.

  1995influential reference
• Myelodysplastic syndromes in childhood--classification, epidemiology, and treatment.

  1994influential reference
• The 5q-syndrome.

  1994cited by this paper
• Establishing the incidence of myelodysplastic syndrome.

  1994cited by this paper
• Myelodysplastic syndromes in children.

  1993cited by this paper
• MYELODYSPLASIC SYNDROMES IN CHILDREN

  1993cited by this paper
• [Myelodysplastic syndromes in children].

  1993cited by this paper
• Proposals for the classification of the myelodysplastic syndromes

  1982cited by this paper

• Cutaneous Manifestations of Pediatric Hematological Malignancies: A Narrative Review

  2025cites this paper
• Resulting Sequelae of an Immunosuppressive State in a Pediatric Patient Status Post Bone Marrow Transplant for the Curative Management of Myelodysplastic Syndrome

  2025cites this paper
• Characteristics and outcomes of children, adolescent, and young adult patients with myelodysplastic neoplasms: A single-center retrospective analysis.

  2024cites this paper
• CanCHD Study of Hematopoietic Cancers in Children With and Without Genetic Syndromes

  2023cites this paper
• Pediatric myelodysplastic syndrome.

  2023cites this paper
• Overview on Pediatric Myelodysplastic Syndrome: A Review

  2021cites this paper
• Is Myelodysplasia a Consequence of Normal Aging?

  2021cites this paper
• Transient abnormal myelopoiesis without constitutional Down syndrome

  2020influential citation
• The altered transcriptome of pediatric myelodysplastic syndrome revealed by RNA sequencing

  2020cites this paper
• A Case of Myelofibrosis and Myelodysplasia Identified Following Exposure to Isotretinoin.

  2019cites this paper
• Myelodysplastic Syndrome (MDS) in a Child who Transformed to Acute Myeloid Leukaemia with Myelodysplasia-Related Changes (AML-MRC)

  2019cites this paper
• The use of antimicrobial photodynamic therapy in oral injuries of a pediatric patient with myelodysplastic syndrome: case report

  2018cites this paper
• Trasplante de células madre hematopoyéticas en pacientes pediátricos con diagnóstico de neoplasias mieloides, experiencia en 15 años

  2018cites this paper
• The prognostic impact of loss of chromosome 7 material detected by fluorescence in situ hybridization (FISH) in myeloid malignancies.

  2018cites this paper
• Increased megakaryocytic proliferation, pro-platelet deposition and expression of fibrosis-associated factors in children with chronic myeloid leukaemia with bone marrow fibrosis

  2017cites this paper
• Abnormal leukocyte scattergrams and immature platelet fraction on Sysmex XN-9000 analyzer: a new diagnostic tool for altered megakaryopoiesis?

  2017influential citation
• Changing the Pathobiological Paradigm in Myelodysplastic Syndromes: The NLRP3 Inflammasome Drives the MDS Phenotype

  2017cites this paper
• Is Myelodysplastic Syndrome a Rarity in Childhood? Or are We Failing to Diagnose?

  2013cites this paper
• Interrogation of EpoR Fidelity in Myelodysplastic Syndrome Hematopoiesis and Stabilization by the Immunomodulatory Agent, Lenalidomide

  2013cites this paper